Evidence map›Paper›PMID 30541497›Full record

ArticleBMC public health2018

Stopping circulatory vaccine-derived poliovirus in Kaduna state by scaling up special interventions in local government areas along rivers of interest- kamacha basin experience, 2013-2015.

Audu I Musa, Faisal Shuaib, Fiona Braka, Pascal Mkanda, Richard Banda, Charles Korir, Sisay G Tegegne, Suleiman Abdullahi, Gregory C Umeh, Terna I Nomhwange and 9 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Audu I MusaWorld Health Organization, Abuja, Nigeria. musaau@who.int.
Faisal ShuaibNational Primary Health Care Agency, Abuja, Nigeria.
Fiona BrakaWorld Health Organization, Abuja, Nigeria.
Pascal MkandaWorld Health Organization, Abuja, Nigeria.
Richard BandaWorld Health Organization, Abuja, Nigeria.
Charles KorirWorld Health Organization, Abuja, Nigeria.
Sisay G TegegneWorld Health Organization, Abuja, Nigeria.
Suleiman AbdullahiWorld Health Organization, Abuja, Nigeria.
Gregory C UmehWorld Health Organization, Abuja, Nigeria.
Terna I NomhwangeWorld Health Organization, Abuja, Nigeria.
Hadiza Aliyu IyalWorld Health Organization, Abuja, Nigeria.
Sambo IshakuWorld Health Organization, Abuja, Nigeria.
Usman AdamuNational Primary Health Care Agency, Abuja, Nigeria.
Eunice DamisaNational Primary Health Care Agency, Abuja, Nigeria.
Murtala BaganaNational Primary Health Care Agency, Abuja, Nigeria.
Victor GugongEmergency Operations Centre (sEOC), Kaduna, Nigeria.
Hadiza BalarabeKaduna State Primary Health Care Agency, Kaduna, Nigeria.
Peter NsubugaGlobal Public Health Solutions, Atlanta, GA, USA.
Rui G VazWorld Health Organization, Abuja, Nigeria.
World Health Organization - Nigeria · NGNational Primary Health Care Development Agency · NGKaduna State University · NGPublic Health Solutions · US

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundThe Kamacha river is one of the five polio environmental surveillance sites in Kaduna State where 13 circulating vaccine-derived polioviruses (cVDPDs) were isolated between 2014 and 2015. Kamacha river accounted for 5 of all reported cVDPVs in Kaduna State between 2014 and 2015. Poor quality Supplemental Immunization Activities (SIAs) and low population immunity have been reported in the 10 LGAs with tributaries that flow into the river. We described the processes of implementing the various health interventions in these targeted LGAs along the Kamacha River and assessed the effectiveness of the interventions in stopping cVDPV in Kaduna, state, Nigeria.

methodsSpecial interventions that had been proven to be functional and effective in reaching unreached children with potent vaccines in the state were scaled up in these targeted 10 LGAs along the Kamacha River. These interventions included revision of house based microplans, scaling up of transit vaccination, scaling up of youth engagement, intensified supportive supervision, scaling up of Directly Observed Polio Vaccination (DOPV) and in-between rounds vaccination activities. We analyzed immunization plus days (IPDs) administrative tally sheet and monitoring data from 10 rounds before and 10 rounds after the special interventions.

resultsThe number of children immunized increased from 1,862,958 in December 2014 before the intervention to 1,922,940 in March 2016 after the intervention. Lot Quality Assurance Sampling (LQAS) results showed an increase in the proportion of LGAs accepted at coverage > 90% after the interventions, from 67% before intervention to 84% after intervention. The proportion of non-polio AFP children with > 4 doses of oral polio vaccine increased from 2 to 8% before to 93-98% after the interventions.. No new environmental cVDPV has been isolated since the introduction of the interventions in April 2015 until July 2016.

conclusionScaling up known working interventions in the 10 LGAs with tributaries that drain to Kamacha River environmental sample site may have contributed to improved immunity and interruption of cVDPV in Kaduna state. These interventions should be replicated in LGAs and states with persistent poliovirus isolation.

Indexed as

Child, PreschoolHumansInfantLocal GovernmentNigeriaPoliomyelitisPoliovirusPoliovirus Vaccine, OralProgram EvaluationRiversPoliovirus Vaccine, OralCirculatory vaccine derived polio-virusNigeriaSpecial interventions

Identifiers

PMID30541497
PMCPMC6291911
OpenAlexW2902181703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.